The chemical structure of LY294002, a PI3K/AKT signaling pathway inhibitor, is shown in Figure S5B. To detect the effect of LY294002 on the viability of AML-12 cells, CCK-8 method was used. This evidence concerns the gene AKT1 and acute myeloid leukemia.